Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
200000 participants
OBSERVATIONAL
2024-10-25
2055-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ATHN 7: Hemophilia Natural History Study
NCT03619863
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
NCT04398628
ATHN 11: Liver Transplantation Outcomes Study
NCT04055051
The Second Multicenter Hemophilia Cohort Study
NCT00341705
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Demographics (e.g., age, gender, income, education/occupation)
* The type of blood disorder you have
* Date you were diagnosed, or symptoms began
* Family history of the disorder
* Testing and assessments
* Physical exams
* Height, weight
* Vital signs, including blood pressure and heart rate
* Laboratory tests (results from blood or urine testing, or biological specimens)
* Genetic test results
* Imaging results (X-rays, CT scans, etc.)
* Pharmacokinetic testing results (how drugs are processed in the body)
* Medications used and any problems with use
* Types of bleeds, pain and clotting problems
* Treatments that stop your bleeding or clotting problems from occurring or getting worse
* Surgeries and/or procedures
* Immunizations (vaccines)
* Devices
* Routine care visits and injuries (trauma)
* Other illnesses and diseases you may have
* Allergies
* Patient-reported outcomes (PROs), questionnaires, and surveys
* Payment details for treatment, including insurance companies and health plans
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood Disorders
The ATHNdataset is a large, robust real-world registry that can be queried to produce curated subsets of data to support clinical care, outcomes analysis, safety monitoring, practice of treatment, advocacy, public health reporting, quality improvement projects, and research initiatives. Initiatives relying on the ATHNdataset may focus on gaining a greater understanding of blood disorders, the complications of these disorders, their social and economic costs, and the effectiveness of treatments.
The population includes all individuals diagnosed with or suspected to have a blood disorder. Participants will contribute data gathered during care encounters with an ATHN Affiliate.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants of any age.
* Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Thrombosis and Hemostasis Network
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tammuella Chrisentery-Singleton, M.D.
Role: PRINCIPAL_INVESTIGATOR
American Thrombosis and Hemostasis Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American Thrombosis and Hemostasis Network
Hickory, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00082318
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.